Role of microbiota-gut-brain axis dysfunctions induced by infections in the onset of anorexia nervosa.

anorexia nervosa anxiety-like behavior bacteria food intake control gut microbiota infection intestinal dysbiosis

Journal

Nutrition reviews
ISSN: 1753-4887
Titre abrégé: Nutr Rev
Pays: United States
ID NLM: 0376405

Informations de publication

Date de publication:
10 02 2022
Historique:
pubmed: 20 5 2021
medline: 31 3 2022
entrez: 19 5 2021
Statut: ppublish

Résumé

Anorexia nervosa (AN) is an eating disorder characterized by low food intake, severe body weight loss, intense fear of gaining weight, and dysmorphophobia. This chronic disease is associated with both psychiatric and somatic comorbidities. Over the years, clinical studies have accumulated evidence that viral or bacterial infections may promote the onset of eating disorders such as AN. This review aims to describe how infections and the subsequent immune responses affect food intake regulation in the short term and also how these processes may lead to long-term intestinal disorders, including gut barrier disruption and gut microbiota dysbiosis, even after the clearance of the pathogens. We discuss in particular how infection-mediated intestinal dysbiosis may promote the onset of several AN symptoms and comorbidities, including appetite dysregulation, functional gastrointestinal disorders, and mood disorders.

Identifiants

pubmed: 34010427
pii: 6278454
doi: 10.1093/nutrit/nuab030
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

381-391

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the International Life Sciences Institute.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Marie Galmiche (M)

Nutrition Department, CHU Rouen, F-76000 Rouen, France.

Najate Achamrah (N)

Nutrition Department, CHU Rouen, F-76000 Rouen, France.
UNIROUEN, INSERM UMR 1073, Nutrition, Gut and Brain Laboratory, Rouen, France.
UNIROUEN, Institute for Research and Innovation in Biomedicine, Normandie University, Rouen, France.

Pierre Déchelotte (P)

Nutrition Department, CHU Rouen, F-76000 Rouen, France.
UNIROUEN, Institute for Research and Innovation in Biomedicine, Normandie University, Rouen, France.

David Ribet (D)

UNIROUEN, INSERM UMR 1073, Nutrition, Gut and Brain Laboratory, Rouen, France.
UNIROUEN, Institute for Research and Innovation in Biomedicine, Normandie University, Rouen, France.

Jonathan Breton (J)

Nutrition Department, CHU Rouen, F-76000 Rouen, France.
UNIROUEN, INSERM UMR 1073, Nutrition, Gut and Brain Laboratory, Rouen, France.
UNIROUEN, Institute for Research and Innovation in Biomedicine, Normandie University, Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH